Mark Pronk

1.1k total citations
11 papers, 295 citations indexed

About

Mark Pronk is a scholar working on Epidemiology, Agronomy and Crop Science and Immunology. According to data from OpenAlex, Mark Pronk has authored 11 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 4 papers in Agronomy and Crop Science and 3 papers in Immunology. Recurrent topics in Mark Pronk's work include Influenza Virus Research Studies (9 papers), Respiratory viral infections research (5 papers) and Animal Disease Management and Epidemiology (4 papers). Mark Pronk is often cited by papers focused on Influenza Virus Research Studies (9 papers), Respiratory viral infections research (5 papers) and Animal Disease Management and Epidemiology (4 papers). Mark Pronk collaborates with scholars based in Netherlands, Belgium and Germany. Mark Pronk's co-authors include Albert D. M. E. Osterhaus, Annemiek A. van der Eijk, Matthias F. C. Beersma, Suzan D. Pas, Robert A. de Man, Guus F. Rimmelzwaan, Ron A. M. Fouchier, Marion Koopmans, Nella J. Nieuwkoop and Rory D. de Vries and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Mark Pronk

9 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Pronk Netherlands 6 150 147 107 74 22 11 295
Y. Khudyakov United States 10 151 1.0× 259 1.8× 82 0.8× 19 0.3× 36 1.6× 15 294
Ashish C. Shrestha Australia 10 139 0.9× 146 1.0× 142 1.3× 24 0.3× 22 1.0× 23 288
Romy Weller Germany 5 75 0.5× 78 0.5× 105 1.0× 13 0.2× 21 1.0× 6 221
Pieter Jooste South Africa 9 132 0.9× 84 0.6× 89 0.8× 61 0.8× 11 0.5× 12 249
Ahlem Ben Yahia Tunisia 12 227 1.5× 78 0.5× 200 1.9× 53 0.7× 27 1.2× 30 383
О. В. Исаева Russia 10 143 1.0× 167 1.1× 104 1.0× 8 0.1× 17 0.8× 45 269
Faustina Pappoe Ghana 11 127 0.8× 52 0.4× 64 0.6× 32 0.4× 32 1.5× 20 273
Sara Paladini Italy 9 207 1.4× 284 1.9× 148 1.4× 29 0.4× 16 0.7× 11 375
Zimin Tang China 11 100 0.7× 392 2.7× 323 3.0× 19 0.3× 22 1.0× 25 457
SA Locarnini Australia 11 187 1.2× 293 2.0× 265 2.5× 19 0.3× 32 1.5× 21 438

Countries citing papers authored by Mark Pronk

Since Specialization
Citations

This map shows the geographic impact of Mark Pronk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pronk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pronk more than expected).

Fields of papers citing papers by Mark Pronk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Pronk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pronk. The network helps show where Mark Pronk may publish in the future.

Co-authorship network of co-authors of Mark Pronk

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Pronk. A scholar is included among the top collaborators of Mark Pronk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Pronk. Mark Pronk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bauer, Lisa, Lonneke Leijten, Willemijn F. Rijnink, et al.. (2025). Attachment and replication of clade 2.3.4.4b influenza A (H5N1) viruses in human respiratory epithelium: an in-vitro study. The Lancet Microbe. 7(1). 101230–101230.
2.
3.
Kok, Adinda, Rachel D. Scheuer, Theo M. Bestebroer, et al.. (2023). Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution. mBio. 14(5). e0048823–e0048823. 4 indexed citations
4.
Rosu, Miruna E., Adinda Kok, Theo M. Bestebroer, et al.. (2022). Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model. Journal of Virology. 96(6). e0195921–e0195921. 9 indexed citations
5.
Vries, Rory D. de, Arwen F. Altenburg, Nella J. Nieuwkoop, et al.. (2018). Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial. The Journal of Infectious Diseases. 218(4). 614–623. 27 indexed citations
6.
Sandt, Carolien E. van de, Mark Pronk, Theo M. Bestebroer, et al.. (2018). H1N1pdm09 Influenza Virus and Its Descendants Lack Extra-epitopic Amino Acid Residues Associated With Reduced Recognition by M158-66-Specific CD8+ T Cells. The Journal of Infectious Diseases. 218(4). 581–585. 5 indexed citations
7.
Sandt, Carolien E. van de, Mark Pronk, Carel A. van Baalen, Ron A. M. Fouchier, & Guus F. Rimmelzwaan. (2018). Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1 58-66 Epitope-Specific CD8 + T Lymphocytes. Journal of Virology. 92(11). 3 indexed citations
8.
Vries, Rory D. de, Nella J. Nieuwkoop, Mark Pronk, et al.. (2016). Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection. Vaccine. 35(2). 238–247. 54 indexed citations
9.
Sandt, Carolien E. van de, Stella E. Vogelzang-van Trierum, Kim B. Westgeest, et al.. (2015). Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage. Journal of General Virology. 96(8). 2061–2073. 42 indexed citations
10.
Pas, Suzan D., Mark Pronk, Robert A. de Man, et al.. (2013). Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. Journal of Clinical Virology. 58(4). 629–634. 150 indexed citations
11.
Pas, Suzan D., et al.. (2012). 563 EVALUATION OF EIGHT COMMERCIAL HEPATITIS E VIRUS SPECIFIC IGM AND IGG ELISA ASSAYS. Journal of Hepatology. 56. S223–S224. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Khudyakov Breakdown of academic impact, for papers by Ashish C. Shrestha Breakdown of academic impact, for papers by Romy Weller Breakdown of academic impact, for papers by Pieter Jooste Breakdown of academic impact, for papers by Ahlem Ben Yahia Breakdown of academic impact, for papers by О. В. Исаева Breakdown of academic impact, for papers by Faustina Pappoe Breakdown of academic impact, for papers by Sara Paladini Breakdown of academic impact, for papers by Zimin Tang Breakdown of academic impact, for papers by SA Locarnini
Rankless by CCL
2026